Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Hormone therapies in pregnancy].

G A Tommaselli1, M Pellicano, M Guida

  • 1Dipartimento di Ginecologia, Ostetricia e Fisiopatologia della Riproduzione Umana, Università degli Studi di Napoli, Federico II, Napoli, Italy.

Minerva Ginecologica
|May 29, 2002
PubMed
Summary

Maternal endocrine disorders pose risks to both mother and fetus during pregnancy. This review examines these conditions, their effects, and safe treatment options for expectant mothers.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chronological age as a major determinant of systemic metabolic remodeling in women.

Experimental gerontology·2026
Same author

Late-Onset Myasthenia Gravis: An Increasingly Frequent Clinical Entity With Distinctive Challenges.

Muscle & nerve·2026
Same author

Challenging Spontaneous Quantum Collapse with the XENONnT Dark Matter Detector.

Physical review letters·2026
Same author

Lipid remodeling and circulating semaphorin 3A in diminished ovarian reserve.

Scientific reports·2026
Same author

Tissue expression of miR-504-5p and miR-429 as diagnostic biomarkers for endometrial cancer and endometrial intraepithelial neoplasia: a pilot study.

The journal of liquid biopsy·2026
Same author

WIMP Dark Matter Search Using a 3.1 Tonne-Year Exposure of the XENONnT Experiment.

Physical review letters·2025

Area of Science:

  • Endocrinology
  • Maternal-Fetal Medicine
  • Pharmacology

Context:

  • Pregnancy can significantly alter the course of maternal endocrine disorders.
  • Endocrine conditions may arise during pregnancy, impacting maternal and fetal health.
  • Therapeutic interventions for endocrine disorders require careful consideration during gestation.

Purpose:

  • To review the incidence and evolution of major maternal endocrine disorders during pregnancy.
  • To discuss the effects of these disorders on maternal and fetal well-being.
  • To explore current and emerging treatment strategies for endocrine conditions in pregnant patients.

Summary:

  • Maternal endocrine disorders present significant risks, affecting both the pregnant individual and the developing fetus.

Related Experiment Videos

  • Assessing the safety of endocrine therapies during pregnancy is crucial, evaluating fetal effects, placental transfer, and teratogenic potential.
  • This review syntheses information on endocrine disorder prevalence, pregnancy-related changes, maternal-fetal impacts, and updated treatment guidelines.

    • Impact:

    • Provides critical information for clinicians managing endocrine disorders in pregnant patients.
    • Highlights the importance of risk-benefit assessments for maternal pharmacotherapy.
    • Contributes to improved understanding and management of endocrine health during pregnancy.